Managers

Tactiva Therapeutics inks $35 mln Series A

Tactiva Therapeutics, a cancer immunotherapy company, has secured $35 million in Series A financing. Panacea Healthcare Partners led the round with participation from other investors that included Vi Ventures and Efung Capital.

SpinTech grabs funding

SpinTech, a developer of software focused on brain scan MRIs, has secured an undisclosed amount of funding. The investor was Genesis Innovation Group's cultivate(MD) Capital.

Persona lands Series A1 funding

Washington-based Persona, a personalized vitamin program, has raised Series A1 financing. Emil Capital and L Catterton led the round. Also, Persona has secured a long-term debt facility from Silicon Valley Bank. No financial terms were disclosed.

Alumina to provide $25 mln to MYM Nutraceuticals

Alumina Partners has inked a term sheet to provide $25 million in funding to MYM Nutraceuticals Inc. Based in Vancouver, British Columbia, MYM Nutraceuticals Inc is an cannabis grower and nutraceuticals manufacturing and distribution company focused on global cannabis markets.

Revive Solutions snags $3.4 mln seed

San Francisco-based Revive Solutions Inc, a developer of an automated external defibrillator, has raised $3.4 million in seed funding. Greenbox Venture Partners led the round with participation from other investors that included Rock Health, HealthTech Capital and Hippocrates VC.

NEA completes secondary sale of 26 portfolio companies for about $1 bln

ViaCyte nabs $80 mln Series D

San Diego-based ViaCyte Inc, a privately-held clinical stage regenerative medicine company, has secured $80 million in Series D financing. The investors included Bain Capital Life Sciences, TPG and RA Capital Management.

Aprea Therapeutics picks up Series C funding

Boston and Stockholm-based Aprea Therapeutics, a clinical-stage biotechnology company developing novel anticancer therapies targeting the p53 tumor suppressor protein, has secured 50 million euros in Series C financing. Redmile Group led the round with participation from Rock Springs Capital, 5AM Ventures, Versant Ventures, HealthCap, Sectoral Asset Management and Karolinska Development AB.

What investors tell their companies

How venture is preparing for a downturn